A solution scan of societal options to reduce transmission and spread of respiratory viruses: SARS-CoV-2 as a case study.
View / Open Files
Authors
Taylor, Nigel G
Rhodes, Catherine
Shackelford, Gorm
Brick, Cameron
Dobson, Andrew P
Downey, Harriet
Hood, Amelia SC
Hua, Fangyuan
Hughes, Alice C
Jarvis, Rebecca M
MacFarlane, Douglas
Mupepele, Anne-Christine
Nelson, Cassidy
Ó hÉigeartaigh, Seán
Sainsbury, Katherine A
Sundaram, Lalitha S
Watkins, John
Willott, Kate
Publication Date
2021-12Journal Title
J Biosaf Biosecur
ISSN
2588-9338
Publisher
Elsevier BV
Volume
3
Issue
2
Pages
84-90
Language
eng
Type
Article
This Version
AM
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Sutherland, W., Taylor, N. G., Aldridge, D., Martin, P., Rhodes, C., Shackelford, G., Beard, S., et al. (2021). A solution scan of societal options to reduce transmission and spread of respiratory viruses: SARS-CoV-2 as a case study.. J Biosaf Biosecur, 3 (2), 84-90. https://doi.org/10.1016/j.jobb.2021.08.003
Abstract
Societal biosecurity - measures built into everyday society to minimize risks from pests and diseases - is an important aspect of managing epidemics and pandemics. We aimed to identify societal options for reducing the transmission and spread of respiratory viruses. We used SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) as a case study to meet the immediate need to manage the COVID-19 pandemic and eventually transition to more normal societal conditions, and to catalog options for managing similar pandemics in the future. We used a 'solution scanning' approach. We read the literature; consulted psychology, public health, medical, and solution scanning experts; crowd-sourced options using social media; and collated comments on a preprint. Here, we present a list of 519 possible measures to reduce SARS-CoV-2 transmission and spread. We provide a long list of options for policymakers and businesses to consider when designing biosecurity plans to combat SARS-CoV-2 and similar pathogens in the future. We also developed an online application to help with this process. We encourage testing of actions, documentation of outcomes, revisions to the current list, and the addition of further options.
Sponsorship
For funding we are grateful to The David and Claudia Harding Foundation, Arcadia and MAVA.
Funder references
NERC (1945942)
Medical Research Council (G1002610)
Medical Research Council (MR/R009120/1)
MRC (MR/V028669/1)
Embargo Lift Date
2024-08-17
Identifiers
External DOI: https://doi.org/10.1016/j.jobb.2021.08.003
This record's URL: https://www.repository.cam.ac.uk/handle/1810/326877
Rights
All rights reserved
Licence:
http://www.rioxx.net/licenses/all-rights-reserved
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.